162 related articles for article (PubMed ID: 24307805)
1. "Metroticket" predictor for assessing liver transplantation to treat hepatocellular carcinoma: a single-center analysis in mainland China.
Lei JY; Wang WT; Yan LN
World J Gastroenterol; 2013 Nov; 19(44):8093-8. PubMed ID: 24307805
[TBL] [Abstract][Full Text] [Related]
2. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
Cucchetti A; Serenari M; Sposito C; Di Sandro S; Mosconi C; Vicentin I; Garanzini E; Mazzaferro V; De Carlis L; Golfieri R; Spreafico C; Vanzulli A; Buscemi V; Ravaioli M; Ercolani G; Pinna AD; Cescon M
J Hepatol; 2020 Aug; 73(2):342-348. PubMed ID: 32201284
[TBL] [Abstract][Full Text] [Related]
3. Validation of the "Metroticket" model in a cohort of patients transplanted for hepatocellular carcinoma in southern Brazil.
Machado A; Kiss G; Ernani L; Marroni C; Zanotelli ML; Cantisani G; Cerski CT; Coral G; Brandão A;
Clin Transplant; 2015 Sep; 29(9):806-12. PubMed ID: 26119109
[TBL] [Abstract][Full Text] [Related]
4. Validation of the "Metroticket" predictor in a cohort of patients transplanted for predominantly HBV-related hepatocellular carcinoma.
Raj A; McCall J; Gane E
J Hepatol; 2011 Nov; 55(5):1063-8. PubMed ID: 21354447
[TBL] [Abstract][Full Text] [Related]
5. Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.
Kim HD; Song GW; Shim JH; Han S; An J; Moon DB; Kim KM; Lim YS; Ko GY; Hwang S; Lee HC; Yu E; Sung KB; Lee SG
Hepatol Int; 2017 Mar; 11(2):209-219. PubMed ID: 28144812
[TBL] [Abstract][Full Text] [Related]
6. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
[TBL] [Abstract][Full Text] [Related]
7. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience.
Lei JY; Wang WT; Yan LN
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):200-4. PubMed ID: 23995766
[TBL] [Abstract][Full Text] [Related]
8. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
[TBL] [Abstract][Full Text] [Related]
9. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
10. Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis.
Lei JY; Wang WT; Yan LN
World J Gastroenterol; 2013 Sep; 19(36):6077-83. PubMed ID: 24106409
[TBL] [Abstract][Full Text] [Related]
11. Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy.
Firl DJ; Kimura S; McVey J; Hashimoto K; Yeh H; Miller CM; Markmann JF; Sasaki K; Aucejo FN
Hepatology; 2018 Oct; 68(4):1448-1458. PubMed ID: 29604231
[TBL] [Abstract][Full Text] [Related]
12. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
Lai Q; Inostroza M; Rico Juri JM; Goffette P; Lerut J
HPB (Oxford); 2015 Dec; 17(12):1085-95. PubMed ID: 26373980
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
[TBL] [Abstract][Full Text] [Related]
15. Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.
Teng F; Wang GH; Tao YF; Guo WY; Wang ZX; Ding GS; Shi XM; Fu ZR
World J Gastroenterol; 2014 Aug; 20(31):10900-7. PubMed ID: 25152592
[TBL] [Abstract][Full Text] [Related]
16. Expanded criteria for hepatocellular carcinoma after liver transplantation: a 20-year evolution.
Lai Q; Nudo F; Mennini G; Spoletini G; Morabito V; Levi SG; Melandro F; Guglielmo N; Berloco PB; Rossi M
Hepatogastroenterology; 2013; 60(128):2039-41. PubMed ID: 24719947
[TBL] [Abstract][Full Text] [Related]
17. Role of [
Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
[TBL] [Abstract][Full Text] [Related]
18. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
[TBL] [Abstract][Full Text] [Related]
19. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center.
Palmer WC; Lee D; Burns J; Croome K; Rosser B; Patel T; Keaveny AP; Pungpapong S; Satyanarayana R; Yataco M; Nakhleh R; Musto KR; Canabal AM; Turnage AK; Hodge DO; Nguyen JH; Harnois DM
Ann Hepatol; 2017; 16(3):402-411. PubMed ID: 28425410
[TBL] [Abstract][Full Text] [Related]
20. Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.
Teng F; Han QC; Ding GS; Ni ZJ; Fu H; Guo WY; Shi XM; Gao XG; Ma J; Fu ZR
Sci Rep; 2015 Jun; 5():11733. PubMed ID: 26096817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
